Tissue Repair Ltd is an Australian biopharmaceutical company founded in 2012. The company focuses on developing advanced wound healing products for chronic wounds. Tissue Repair has created a unique active ingredient designed for wound healing and topical delivery. This ingredient mimics a yeast infection, acting as a decoy cell and stimulating the body’s natural wound repair pathways. The innovative technology not only targets chronic wounds but also holds potential for applications in cosmetic procedures. With a stronghold in Biopharma, Biotechnology, and Pharmaceutical industries, the company's active ingredient offers a platform for developing a range of products across the wound care market. The startup has yet to disclose its last investment details and investors.
There is no investment information
No recent news or press coverage available for Tissue Repair.